Naloxegol and Opioid-induced Constipation

Clinical trial NCT03316859 · UNKNOWN

Trial details

NCT number: NCT03316859
Sponsor: TriHealth Inc.
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Constipation Constipation Drug Induced

Start date: 2017-11-06
Primary completion: 2022-12-01
Enrollment: 280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.